Bill Text: TX HB4145 | 2019-2020 | 86th Legislature | Introduced
Bill Title: Relating to the prescription of a controlled substance to certain patients for the treatment of pain.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2019-05-01 - Left pending in committee [HB4145 Detail]
Download: Texas-2019-HB4145-Introduced.html
| By: Zwiener | H.B. No. 4145 | |
|
|
||
|
|
||
| relating to the prescription of a controlled substance to certain | ||
| patients for the treatment of pain. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Subchapter C, Chapter 481, Health and Safety | ||
| Code, is amended by adding Section 481.0725 to read as follows: | ||
| Sec. 481.0725. PRESCRIPTION OF CONTROLLED SUBSTANCE AFTER | ||
| DRUG TEST. A practitioner may not refuse to prescribe a controlled | ||
| substance for the treatment of pain to a patient solely because the | ||
| results of a drug test taken by the patient indicated that | ||
| tetrahydrocannabinol or cannabidiol was present in the patient's | ||
| body, or refuse to continue to treat the patient. | ||
| SECTION 2. The change in law made by this Act applies only | ||
| to a prescription issued on or after the effective date of this Act. | ||
| A prescription issued before the effective date of this Act is | ||
| governed by the law in effect on the date the prescription is | ||
| issued, and the former law is continued in effect for that purpose. | ||
| SECTION 3. This Act takes effect September 1, 2019. | ||
